跳至主要内容
临床试验/NCT01502748
NCT01502748终止不适用

Magnesium Therapy: a Novel Platform for Neuroprotectant Sampling in Acute Stroke

University of Southern California4 个研究点 分布在 1 个国家目标入组 2 人开始时间: 2012年3月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
2
试验地点
4
主要终点
Magnesium concentration

研究概览

简要总结

This investigation will address the safety and feasibility of distal, intra-arterial sampling through endovascular access, in acute stroke patients. Levels of Magnesium will be measured in the region of infarct in patients who had been treated with intravenous Magnesium therapy following an acute stroke. This study attempts to address whether the traditional intravenous means of neuroprotectant administration achieves adequate concentration of the therapeutic agent in the area of diseased tissue.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
40 Years 至 95 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient with acute cerebral ischemia due to ICA or MCA occlusion,
  • Patient already enrolled in the NIH FAST-MAG clinical trial,
  • Patient's clinical attending physician plans mechanical embolectomy procedure as part of routine clinical care.
  • Age 40-95 inclusive (age criteria for FAST-MAG Trial).

排除标准

  • Technical inability to navigate microcatheter to target clot.
  • Patient or surrogate unavailable for consent

研究组 & 干预措施

Endovascular Sampling

Experimental

Paired sampling from the distal arterial(endovascular catheter) and peripheral venous (femoral sheath) locations in acute stroke patients undergoing endovascular recanalization who received intravenous Magnesium Sulfate as a part of the FAST-MAG study

干预措施: endovascular sampling (Other)

结局指标

主要结局

Magnesium concentration

时间窗: intra-procedure (at time of first pass of retrieval device)

The primary endpoint is the relative concentration of Mg in the core cerebral ischemic zone, compared to systemic therapeutic Mg levels, as a measure of delivery efficacy of systemic administration.

次要结局

  • Sampling feasibility(intra-procedural (at time of first pass of retrieval device))
  • Safety(post-operative day 1)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

William Mack

Assistant Professor of Neurosurgery

University of Southern California

研究点 (4)

Loading locations...

相似试验